Results 1 to 10 of about 31,806 (309)

Association of asthma and anti-asthmatic therapy with oral health and microbiota alterations in children - a cross-sectional study [PDF]

BMC Pediatrics
Background Asthma and its treatments are recognized as risk factors for oral health in children. The composition of oral microbiota is linked to asthma, as well as to the development of caries and other oral conditions.
Vojko Berce, Boris Egić, Anja Pintaric Lonzaric, Maja Rupnik, Aleksander Mahnic   +4 more
doaj   +2 more sources

Mast cell tryptase and asthma [PDF]

Mediators of Inflammation, 1997
Recent physiological and pharmacological studies have indicated the potential importance of tryptase, the major protein component in mast cells, in inflammatory diseases (especially asthma).
M-Q. Zhang, H. Timmerman
doaj   +5 more sources

Asthma and Therapeutics: Recombinant Therapies in Asthma [PDF]

Allergy, Asthma & Clinical Immunology, 2005
Numerous recombinant therapies are being investigated for the treatment of asthma. This report reviews the current status of several of these novel agents.
Cockcroft Donald W
doaj   +3 more sources

Does bronchial asthma influences dental health of the diseased children? [PDF]

Vojnosanitetski Pregled, 2022
Background/Aim. Asthma is a chronic inflammatory lung disorder. The effect of asthma drugs on oral health is still the subject of debate among researchers in dentistry.
Davidović Bojana, Ivanović Mirjana, Bokonjić Dejan, Janković Svjetlana, Erić Jelena, Lečić Jelena, Jovičić Olivera   +6 more
doaj   +1 more source

Inhalation therapy in the next decade : Determinants of adherence to treatment in asthma and COPD [PDF]

, 2018
Peer reviewedPublisher ...
Amaducci, Sandro, Bacci, Elena, Baldacci, Sandra, Bartoli, Maria L., Beghi, Gianfranco M., Benfante, Alida, Brighindi, Sara, Casali, Lucio, Castiglia, Daniela, Cazzola, Mario, Celi, Alessandro, Cianchetti, Silvana, Colombo, Giorgio, Crimi, Claudia, d'Alcontres, Martina Stagno, Dente, Federico L., Di Maria, Annalisa, Di Maria, Giuseppe, Donner, Claudio F., Hui Xin, Shaylynn Yu, Latorre, Manuela, Lavorini, Federico, Maio, Sara, Mannini, Claudia, Messina, Riccardo, Paggiaro, Pier Luigi, Pignatti, Patrizia, Pistolesi, Massimo, Price, David, Scichilone, Nicola, Simoni, Marzia, Spanevello, Antonio, Tan, Shwana, Torchio, Roberto, Viegi, Giovanni, Visca, Dina, Wouters, Emiel F.M.   +36 more
core   +16 more sources

Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma

Pharmacological Research, 2022
Asthma is a major respiratory disorder characterised by chronic inflammation and airway remodelling. It affects about 1–8% of the global population and is responsible for over 461,000 deaths annually.
Emmanuel Oshiogwe Okwuofu, Audrey Chee Hui Yong, Jonathan Chee Woei Lim, Johnson Stanslas   +3 more
doaj   +1 more source

Perception of Illness and Fear of Inhaled Corticosteroid Use among Parents of Children with Asthma

Children, 2023
The most prevalent children’s chronic disease worldwide is asthma which has notable negative impacts on patients’ and parent’s quality of life. Daily inhaled corticosteroids (ICS) therapy is a preferred controller choice.
Jasna Petric Duvnjak, Emilija Lozo Vukovac, Anita Ursic, Antonela Matana, Ivana Medvedec Mikic   +4 more
doaj   +1 more source

Adherence to inhalers and associated factors among adult asthma patients: an outpatient-based study in a tertiary hospital of Rajshahi, Bangladesh

Asthma Research and Practice, 2022
Background Adherence to inhaler medication is an important contributor to optimum asthma control along with adequate pharmacotherapy. The objective of the present study was to assess self-reported adherence levels and to identify the potential factors ...
Md. Abdur Rafi, Chowdhury Ibtida Tahmin, Symom Tashrik, Atia Sharmin Bonna, Ferdousy Jannat, Sabrina Jahan Mily, Abhigan Babu Shrestha, Senjuti Seemanta, Afsana Rashid, Mosarrat Mahjabeen, Nurunnahar Nura, Tasnim Shahriar, Ashrafur Rahaman Mahadi, Kawser Ahmed, Mohammad Jahid Hasan, Md. Azizul Haque, Md. Golam Hossain   +16 more
doaj   +1 more source

Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: Meta-analysis [PDF]

Vojnosanitetski Pregled, 2018
Background/Aim. Reslizumab is humanized monoclonal antibody produced by recombinant DNA technology which binds to circulating interleukin-5 (IL-5) and down-regulates the IL-5 signaling pathway. Reslizumab is indicated for the add-on maintenance treatment
Milosavljević Miloš N., Janković Slobodan M., Pejčić Ana V., Milovanović Jasmina R., Opančina Valentina D., Kostić Marina J.   +5 more
doaj   +1 more source

Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]

, 2016
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA, DUSE, MARZIA, Laitano, Rossella, LEONARDI, LUCIA   +3 more
core   +1 more source